Venture capitalist Chamath Palihapitiya responded “What?!?!?!” on X, amplifying analyst Cremieux‘s post describing Eli Lilly ...

The study involved 35 participants with heterozygous familial hypercholesterolaemia or premature coronary artery disease.

Eli Lilly and Company (NYSE:LLY) is one of the. 10 Strong Buy S&P 500 Stocks to Invest In. On May 4, 2026, Wolfe Research said the FDA received a report on April 30 through its Ad ...

Data from the Phase 1b Heart-2 study showed LDL cholesterol reductions of up to 62% among patients who received the highest dose. Researchers said the effects remained visible for as long as 18 months ...

Assembling information about adverse reactions to drugs vexes pharmaceutical companies, which are required to produce reports on any incidents to federal regulators. The far-flung data arrives in ...

It won't come cheap, as Eli Lilly is paying $6.3 billion in up-front payments in the deal. The pharmaceutical giant is also on the hook for up to $1.5 billion in milestone payments. Typically, when a ...